Autologous Adipose-derived Mesenchymal Stem Cells Therapy(CellinCells)

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameAutologous Adipose-derived Mesenchymal Stem Cells Therapy(CellinCells)
Drug Alias NameTRTP-101
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellinCells
China Registration ClassN/A

Develop Information

Active CompaniesCellinCells
Inactive CompaniesN/A
Active IndicationsCicatrix
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A